Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
RegenX Science
AddedFeb 16, 2024
UpdatedJun 18, 2026
RegenX Science

RegenX Science

Series A

RegenX pioneers in regenerative medicine for youthful skin, ensuring FDA compliance through a scientific advisory board.

HQ
West Palm Beach, FL, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

RegenX Science, founded with a mission to harness regenerative medicine for youthful skin, focuses on developing innovative solutions to prevent and potentially reverse early aging and environmental skin damage. Their core product is a new active cosmetic ingredient designed to promote natural and visibly beneficial skin healing. RegenX ensures all products comply with FDA regulations, supported by a dedicated scientific advisory board. The company targets the skincare market, emphasizing scientifically-backed, effective treatments.

Notable figures affiliated with RegenX Science include members of their scientific advisory board, who bring expertise to ensure the efficacy and safety of their products. The company has achieved significant milestones in developing their proprietary cosmetic ingredient, which is built on decades of foundational research. RegenX's impact is evident in its commitment to advancing skincare through regenerative medicine, offering promising solutions for maintaining youthful skin and addressing environmental damage.

RegenX Science - Similar Companies

Repairogen logo

Repairogen

BioRegenx logo

BioRegenx

bioregenx.com

Regenemed logo

Regenemed

regenemed.com

AgeX Therapeutics logo

AgeX Therapeutics

RegenX logo

RegenX

CarthroniX logo

CarthroniX

carthronix.com

Stemgenics logo

Stemgenics

stemgenics.com

Regenerex Pharma logo

Regenerex Pharma

SironRX Therapeutics logo

SironRX Therapeutics

sironrx.com

OneSkin logo

OneSkin

Personal Cell Sciences logo

Personal Cell Sciences

RegeneRx Biopharmaceuticals logo

RegeneRx Biopharmaceuticals

Regen BioPharma logo

Regen BioPharma

EternoGen logo

EternoGen

InGeneron logo

InGeneron

ingeneron.com

RegenX Science - Quick Facts

Who are RegenX Science's competitors?

Companies similar to RegenX Science include Repairogen, BioRegenx, Regenemed and AgeX Therapeutics.

When was RegenX Science founded?

RegenX Science was founded in 2016.

Where is RegenX Science's headquarters located?

RegenX Science's headquarters is located in West Palm Beach, FL, US.

When was RegenX Science's last funding round?

RegenX Science's most recent funding round was for $5M (USD) in September 2022.

How much has RegenX Science raised to-date?

As of Sep 20, 2022, RegenX Science has raised a total of $5M (USD).

How many employees does RegenX Science have?

RegenX Science has 30 employees as of Feb 5, 2024.

RegenX Science - Classification

Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Cosmetics
  • Skincare
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified